Home / Systemic hormones / Dexamethasone
ATC H02AB02 · Glucocorticoids
Dexamethasone shortage
As of 2 Nov 2026, Dexamethasone has a reported shortage in 10 of the 16 countries we track (United States, Canada, Germany, France, Italy, Austria, Belgium, Switzerland, Sweden, Australia), covering 26 products from 12 companies.
Countries10/16
Products26packs or presentations
Companies124 listed
Short since8 Feb 20197.7 years ago
Earliest return13 Nov 2026company estimate
Main reasonIncreased demand
United States2 products shortCanada5 products shortGermany6 products shortFrance1 product shortItaly7 products shortSpainNo reported shortageIrelandNo reported shortageAustria1 product shortBelgium1 product shortSwitzerland1 product shortCzechiaNo reported shortageNorwayNo reported shortageSweden1 product shortJapanNo reported shortageNew ZealandNo reported shortageAustralia1 product short
Timeline
United StatesCanadaGermanyFranceItalyAustriaBelgiumSwitzerlandSwedenAustralia
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Fresenius Kabi FRE · Xetra, Sandoz SDZ · SIX Swiss, Teva TEVA · NYSE / TASE, Aspen APN · JSE
Compared with similar medicines
ATC group H02AB · GlucocorticoidsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Fresenius Kabi USA, LLC | 8 Feb 2019 | not given | Increased demand Demand increase for the drug |
| US | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Fresenius Kabi USA, LLC | 8 Feb 2019 | not given | Not stated |
| CA | DEXAMETHASONE-OMEGA (5 x 5mL vial / fiole) | OMEGA LABORATORIES LIMITED | 26 Nov 2025 | 31 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DEXAMETHASONE-OMEGA (10 x 1 mL vial / fiole) | OMEGA LABORATORIES LIMITED | 20 Feb 2026 | 31 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DEXAMETHASONE OMEGA UNIDOSE (10 x 1 mL vial / fiole) | OMEGA LABORATORIES LIMITED | 21 Jul 2026 | 31 May 2027 | Increased demand Demand increase for the drug |
| CA | DEXAMETHASONE-OMEGA (10 x 25mL vial) | OMEGA LABORATORIES LIMITED | 12 Aug 2026 | not given | Increased demand Demand increase for the drug |
| CA | DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP (1ML 10LIVI) | SANDOZ CANADA INCORPORATED | 26 Oct 2026 | 13 Nov 2026 | Increased demand Demand increase for the drug |
| DE | Dexahexal 4 mg | H e x a l Aktiengesellschaft | 12 Feb 2026 | 31 Dec 2026 | Other Sonstige |
| DE | Dexamethason 1,5 mg Jenapharm | Mibe GmbH Arzneimittel | 1 Jun 2026 | 29 Jan 2027 | Other Sonstige |
| DE | Dexa-inject mibe 4 mg/ml | Mibe GmbH Arzneimittel | 1 Jun 2026 | 29 Jan 2027 | Other Sonstige |
| DE | Dexa-inject mibe 4 mg/ml | Mibe GmbH Arzneimittel | 1 Jun 2026 | 29 Jan 2027 | Other Sonstige |
| DE | Dexa-inject mibe 4 mg/ml | Mibe GmbH Arzneimittel | 1 Jun 2026 | 29 Jan 2027 | Other Sonstige |
| DE | Dexa-inject mibe 10 mg/ml | Mibe GmbH Arzneimittel | 2 Sep 2026 | 29 Jan 2027 | Other Sonstige |
| FR | Dexocol 1 mg/mL, collyre en solution limited | 5 Mar 2025 | not given | Not stated | |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 1 Apr 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 1 Oct 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 4 Dec 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 4 Dec 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | DESAMETASONE KALCEKS | AS KALCEKS | 1 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DESAMETASONE KALCEKS | AS KALCEKS | 1 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DESAMETASONE HAMELN anticipated | HAMELN PHARMA GMBH | 27 Nov 2026 | 31 Jan 2027 | Increased demand Elevata richiesta |
| AT | Dexabene 4 mg - Ampullen, 5 Stück limited | Teva B.V. | 5 Oct 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Aacidexam 5 mg/ml inj. sol. i.m./i.v./i.burs./i.artic. amp. 10 x 1 ml | Aspen Pharma Trading | 23 Oct 2026 | 13 Nov 2026 | Manufacturing problem Delay in production |
| CH | MEPHAMESON Inj Lös 50 mg/3ml 5 Amp 3 ml MEPHAMESON Inj Lös 50 mg/3ml 25 Amp 3 ml | Mepha Pharma AG | 13 Oct 2026 | 23 Nov 2026 | Not stated |
| SE | Dexacur 4 mg/ml Ampull, 3 x 1 ml | Abboxia AB | 1 Jul 2026 | 15 Dec 2026 | Not stated |
| AU | DEXAMETHASONE JUNO dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/1 mL solution for injection ampoule limited | 15 Oct 2026 | 20 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.